APR 10, 2019 09:00 AM PDT

CRISPR Proteins: Enabling the Next-Generation of Molecular Diagnostics

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Senior Scientist, Mammoth Biosciences
    Biography
      Dr. James Broughton is a Senior Scientist at Mammoth Biosciences. James attended Cornell University for his bachelor's degree in Biology, where he began his career long interest in RNA binding proteins. He then went on to receive his doctorate from UC San Diego. During his graduate work, James applied CRISPR/Cas9 genome editing in the nematode worm C. elegans to investigate the function and specificity of microRNAs. For his postdoc, he joined the lab of Dr. Howard Chang at Stanford University. At Stanford, James examined role of RNA modifications on a newly discovered class of RNA, called circular RNAs. After his postdoc, James brought his expertise in RNA biology and CRISPR systems to Mammoth Biosciences where he works on developing and evaluating new CRISPR-based diagnostic technologies.

    Abstract:

    Mammoth Biosciences is developing next-generation CRISPR platforms to build rapid, point-of-care molecular diagnostics. Our innovative DETECTR technology leverages novel CRISPR proteins whose unique biochemical properties make them well-suited for diagnostic applications . By simply altering the nucleotides in their guide RNA (gRNA), CRISPR proteins can be programmed to find and cut any matching DNA or RNA sequence. These unique CRISPR variants additionally interrogate target nucleic acids with single-nucleotide specificity, and they then function themselves as the catalyst for real-time signal detection. The simplicity of CRISPR has already revolutionized the field of gene editing, and is now enabling a new class of diagnostics. Mammoth Biosciences leverages our diverse CRISPR protein portfolio to build a diagnostic platform that is readily scalable to detect any nucleic acid biomarker of interest.

    Learning Objectives:

    1. Develop a general understanding of the diversity of CRISPR-Cas systems
    2. Understand how CRISPR-Cas systems can be used for diagnostic applications


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    JUL 30, 2019 10:00 AM PDT
    C.E. CREDITS
    JUL 30, 2019 10:00 AM PDT
    DATE: July 30, 2019TIME: 10:00am PT/ 1:00pm ET The importance of building a validation structure within your lab cannot be overstated. Once in place, the ability to identify high...
    JUN 26, 2019 09:00 AM PDT
    C.E. CREDITS
    JUN 26, 2019 09:00 AM PDT
    DATE: June 26, 2019TIME: 9:00am PDT, 12:00pm EDT An excessive number of software solutions are available to help manage your clinical, biobank, or biorepository sample inform...
    Loading Comments...
    Show Resources